Association of Androgenetic Alopecia with Benign Prostatic Hyperplasia: A Case Control Study

    March 2018 in “ Nepal journal of dermatology, venereology & leprology ”
    Manoj K. Chaudhary, Sudha Agrawal, Chandra Shekhar Agrawal
    Image of study
    TLDR Hair loss linked to prostate enlargement; stress and family history important factors.
    A case control study from 5 years ago found a significant association between androgenetic alopecia (AGA) and benign prostatic hyperplasia (BPH) in men aged 20 years and above. The study included 176 cases of AGA and 117 healthy controls. Emotional stress was identified as a major factor for AGA, and family history of AGA was present in a significantly higher number of patients than controls. However, some studies found no significant association between AGA and BPH. Overall, further research with larger sample sizes is needed to investigate the relationship between BPH and other risk factors with AGA.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Massive study on finasteride side effects released

      in Finasteride/Dutasteride  83 upvotes 1 year ago
      The release of a study on 5a-reductase inhibitors (finasteride and dutasteride) which showed an increased risk of depression, dementia, decreased libido, and reduced semen load as potential side effects; discussion around other forms of hair loss treatments such as topical minoxidil, RU58841, or opting to accept baldness; and advice to consider professional help for deeper issues related to hair loss.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 3 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Hair Loss Drugs Ranked in Order of Efficacy

      in Research/Science  67 upvotes 1 year ago
      Dutasteride is likely the most effective treatment for male pattern baldness, followed by finasteride and minoxidil in various forms and dosages. Users discuss personal experiences, dosages, and potential side effects, with some considering combining treatments for better results.

      community Why does finasteride stop working?

      in Finasteride/Dutasteride  26 upvotes 2 months ago
      Finasteride may seem less effective over time due to increased DHT sensitivity or aging, but it still suppresses DHT. Switching to dutasteride offers stronger DHT suppression but may increase estrogen levels.

      community Male pattern baldness, and mental health

      in Finasteride/Dutasteride  331 upvotes 10 months ago
      A 48-year-old man has been using minoxidil for 15 years and considered finasteride but stopped due to potential side effects. He is concerned about his mental health and the impact of hair loss on self-image, and he encourages support among men experiencing hair loss.

    Similar Research

    5 / 1000+ results